In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients

被引:0
|
作者
Tomasz Olszak
Paulina Zarnowiec
Wieslaw Kaca
Katarzyna Danis-Wlodarczyk
Daria Augustyniak
Pavel Drevinek
Anthony de Soyza
Siobhán McClean
Zuzanna Drulis-Kawa
机构
[1] University of Wroclaw,Institute of Genetics and Microbiology
[2] The Jan Kochanowski University,Division of Gene Technology
[3] Catholic University of Leuven,Department of Medical Microbiology, University Hospital Motol and 2nd Faculty of Medicine
[4] Charles University,Institute of Cellular Medicine, Medical School
[5] Newcastle University,Centre of Microbial Host Interactions
[6] Institute of Technology Tallaght,undefined
来源
关键词
bacteriophages; Phage treatment; Cystic fibrosis; model;
D O I
暂无
中图分类号
学科分类号
摘要
The goal of the study was to determine the relationship between in vitro/in vivo efficacy of environmental Pseudomonas phages and certain phenotypical properties of Pseudomonas aeruginosa (PA) strains. We studied the diversity between particular isolates and determined phage sensitivity in vitro and in vivo in the Galleria mellonella insect model. Twenty-eight lytic bacteriophages specific for PA were tested against 121 CF PA isolates including 29 mucoid PA strains. Most strains from cystic fibrosis (CF) patients were lysed by at least three phages (93.6 %), but completely insensitive strains were also present (6.4 %). Two phages PA5oct and KT28 exhibited high rates of lytic potency on 55–68 % of PA strains (72–86 % of mucoid isolates). We further explored phage activity against six PA strains (CF and non-CF) in vitro, comparing clonal differences in phage susceptibility with bacterial properties such as the ability to form biofilms, mucosity, twitching motility, and biochemical profiles. We observed the relationship between variation in phage susceptibility and Fourier transform infrared spectroscopy (FTIR) analysis in the spectra window of carbohydrates. The protective efficacy of two selected phages against PA PAO1 and 0038 infection was confirmed in vivo in G. mellonella larvae. Generally, the wax moth model results confirmed the data from in vitro assays, but in massive infection of CF isolates, the application of lytic phages probably led to the release of toxic compound causing an increase in larvae mortality. We assumed that apart of in vitro phage activity testing, a simple and convenient wax moth larvae model should be applied for the evaluation of in vivo effectiveness of particular phage preparations.
引用
收藏
页码:6021 / 6033
页数:12
相关论文
共 50 条
  • [21] In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
    Guezel, Cagla Bozkurt
    Gerceker, A. Alev
    CHEMOTHERAPY, 2008, 54 (02) : 147 - 151
  • [22] Bacteriophages turbo-charge Pseudomonas aeruginosa evolution in patients with cystic fibrosis
    James, Chloe E.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (08) : 447 - 447
  • [23] In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa
    Liu, Zhenqiu
    Lin, Yaying
    Lu, Qi
    Li, Fang
    Yu, Jialin
    Wang, Zhengli
    He, Yu
    Song, Chao
    INFECTION, 2017, 45 (01) : 23 - 31
  • [24] In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa
    Zhenqiu Liu
    Yaying Lin
    Qi Lu
    Fang Li
    Jialin Yu
    Zhengli Wang
    Yu He
    Chao Song
    Infection, 2017, 45 : 23 - 31
  • [25] In Vivo Proteome of Pseudomonas aeruginosa in Airways of Cystic Fibrosis Patients
    Wu, Xia
    Siehnel, Richard J.
    Garudathri, Jayanthi
    Staudinger, Benjamin J.
    Hisert, Katherine B.
    Ozer, Egon A.
    Hauser, Alan R.
    Eng, Jimmy K.
    Manoil, Colin
    Singh, Pradeep K.
    Bruce, James E.
    JOURNAL OF PROTEOME RESEARCH, 2019, 18 (06) : 2601 - 2612
  • [26] In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Nolan, Patrick J.
    Jain, Raksha
    Cohen, Leah
    Finklea, James D.
    Smith, Tiffeny T.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (02)
  • [27] Liposome-mediated gentamicin delivery:: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients
    Mugabe, C
    Azghani, AO
    Omri, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (02) : 269 - 271
  • [28] Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis
    Kanwar, Neena
    Harrison, Christopher J.
    Pence, Morgan A.
    Qin, Xuan
    Selvarangan, Rangaraj
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 105 (04)
  • [29] NONOPSONIC PHAGOCYTOSIS OF STRAINS OF PSEUDOMONAS-AERUGINOSA FROM CYSTIC-FIBROSIS PATIENTS
    SPEERT, DP
    EFTEKHAR, F
    PUTERMAN, ML
    INFECTION AND IMMUNITY, 1984, 43 (03) : 1006 - 1011
  • [30] Various typing methods of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
    Hafiane, A.
    Ravaoarinoro, M.
    MEDECINE ET MALADIES INFECTIEUSES, 2008, 38 (05): : 238 - 247